The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-methyl-4-(4-(phenylamino)pyrido[3,2-d]pyrimidin-6-yl)benzamide ID: ALA4861078
PubChem CID: 153526779
Max Phase: Preclinical
Molecular Formula: C21H17N5O
Molecular Weight: 355.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1ccc(-c2ccc3ncnc(Nc4ccccc4)c3n2)cc1
Standard InChI: InChI=1S/C21H17N5O/c1-22-21(27)15-9-7-14(8-10-15)17-11-12-18-19(26-17)20(24-13-23-18)25-16-5-3-2-4-6-16/h2-13H,1H3,(H,22,27)(H,23,24,25)
Standard InChI Key: MEOVZYBGIKUMJJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
18.4443 -9.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1540 -9.5522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1511 -8.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4425 -8.3243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7363 -9.5527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7375 -8.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8623 -9.9597 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8636 -10.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1552 -11.1851 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1562 -12.0015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8692 -12.3561 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5700 -11.1806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5717 -11.9920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2740 -12.3944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9752 -11.9867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9696 -11.1723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2667 -10.7735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6713 -10.7577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3823 -11.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0865 -10.7499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0811 -9.9319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3655 -9.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6641 -9.9439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7853 -9.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4964 -9.9198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2006 -9.5052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7783 -8.7001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
2 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 13 1 0
12 8 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
16 18 1 0
21 24 1 0
24 25 1 0
25 26 1 0
24 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.40Molecular Weight (Monoisotopic): 355.1433AlogP: 3.80#Rotatable Bonds: 4Polar Surface Area: 79.80Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.96CX Basic pKa: 4.72CX LogP: 3.74CX LogD: 3.73Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.58Np Likeness Score: -1.34
References 1. Han Y, Zhang H, Wang S, Li B, Xing K, Shi Y, Cao H, Zhang J, Tong T, Zang J, Guan L, Gao X, Wang Y, Liu D, Huang M, Jing Y, Zhao L.. (2021) Optimization of 4,6-Disubstituted Pyrido[3,2-d ]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell Growth., 64 (18.0): [PMID:34515481 ] [10.1021/acs.jmedchem.1c01084 ]